141 related articles for article (PubMed ID: 12751371)
21. Impact of a dosimetry review program on radiotherapy in group trials.
Reinstein LE; Peachey S; Laurie F; Glicksman AS
Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1179-84. PubMed ID: 3888935
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy dosimetry audit: three decades of improving standards and accuracy in UK clinical practice and trials.
Clark CH; Aird EG; Bolton S; Miles EA; Nisbet A; Snaith JA; Thomas RA; Venables K; Thwaites DI
Br J Radiol; 2015; 88(1055):20150251. PubMed ID: 26329469
[TBL] [Abstract][Full Text] [Related]
23. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
Sassowsky M; Gut P; Hölscher T; Hildebrandt G; Müller AC; Najafi Y; Kohler G; Kranzbühler H; Guckenberger M; Zwahlen DR; Azinwi NC; Plasswilm L; Takacs I; Reuter C; Sumila M; Manser P; Ost P; Böhmer D; Pilop C; Aebersold DM; Ghadjar P
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):534-41. PubMed ID: 23972722
[TBL] [Abstract][Full Text] [Related]
24. Quality assurance in Health Services: the paradigm of radiotherapy.
Papakostidi A; Tolia M; Tsoukalas N
J BUON; 2014; 19(1):47-52. PubMed ID: 24659642
[TBL] [Abstract][Full Text] [Related]
25. Dosimetric inter-institutional comparison in European radiotherapy centres: Results of IAEA supported treatment planning system audit.
Gershkevitsh E; Pesznyak C; Petrovic B; Grezdo J; Chelminski K; do Carmo Lopes M; Izewska J; Van Dyk J
Acta Oncol; 2014 May; 53(5):628-36. PubMed ID: 24164104
[TBL] [Abstract][Full Text] [Related]
26. Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review.
Ataman F; Poortmans P; Stupp R; Fisher B; Mirimanoff RO
Eur J Cancer; 2004 Jul; 40(11):1724-30. PubMed ID: 15251162
[TBL] [Abstract][Full Text] [Related]
27. Quality assurance in the treatment of colorectal cancer: the EURECCA initiative.
Breugom AJ; Boelens PG; van den Broek CB; Cervantes A; Van Cutsem E; Schmoll HJ; Valentini V; van de Velde CJ
Ann Oncol; 2014 Aug; 25(8):1485-92. PubMed ID: 24671742
[TBL] [Abstract][Full Text] [Related]
28. Multidisciplinary quality assurance and control in oncological trials: Perspectives from European Organisation for Research and Treatment of Cancer (EORTC).
;
Eur J Cancer; 2017 Nov; 86():91-100. PubMed ID: 28964907
[TBL] [Abstract][Full Text] [Related]
29. From technical quality assurance of radiotherapy to a comprehensive quality of service management system.
Kehoe T; Rugg LJ
Radiother Oncol; 1999 Jun; 51(3):281-90. PubMed ID: 10435823
[TBL] [Abstract][Full Text] [Related]
30. Profile of radiotherapy departments contributing to the Cooperative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer.
Bernier J; Horiot JC; Bartelink H; Johansson KA; Cionini L; Gonzalèz Gonzalèz D; Hamers H; van den Bogaert W
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):953-60. PubMed ID: 8598375
[TBL] [Abstract][Full Text] [Related]
31. International Clinical Trials in Radiation Oncology. Quality assurance/physics/dosimetry.
Suntharalingam N; Johansson KA
Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S21-4. PubMed ID: 3292478
[No Abstract] [Full Text] [Related]
32. High conformality radiotherapy in Europe: thirty-one centres participating in the quality assurance programme of the EORTC prostate trial 22991.
Ataman F; Poortmans P; Davis JB; Bernier J; Giraud JY; Kouloulias VE; Pierart M; Bolla M
Eur J Cancer; 2004 Nov; 40(16):2411-6. PubMed ID: 15519513
[TBL] [Abstract][Full Text] [Related]
33. Quality assurance for 3D conformal radiation therapy.
Purdy JA; Harms WB
Strahlenther Onkol; 1998 Oct; 174 Suppl 2():2-7. PubMed ID: 9810330
[TBL] [Abstract][Full Text] [Related]
34. Radiotherapy quality assurance by individualized in vivo dosimetry: state of the art.
Ismail A; Giraud JY; Lu GN; Sihanath R; Pittet P; Galvan JM; Balosso J
Cancer Radiother; 2009 Jun; 13(3):182-9. PubMed ID: 19272824
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy in England in 2007: modelled demand and audited activity.
Williams MV; Drinkwater KJ
Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):575-90. PubMed ID: 19651499
[TBL] [Abstract][Full Text] [Related]
36. Quality assurance of radiotherapy in cancer treatment: toward improvement of patient safety and quality of care.
Ishikura S
Jpn J Clin Oncol; 2008 Nov; 38(11):723-9. PubMed ID: 18952706
[TBL] [Abstract][Full Text] [Related]
37. Multi-institutional clinical trials: 3-D conformal radiotherapy quality assurance. Guidelines in an NCI/RTOG study evaluating dose escalation in prostate cancer radiotherapy.
Purdy JA; Harms WB; Michalski J; Cox JD
Front Radiat Ther Oncol; 1996; 29():255-63. PubMed ID: 8742907
[No Abstract] [Full Text] [Related]
38. [A proposal for reforming psychologists' training in France and in the European Union].
Bouchard JP
Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
[TBL] [Abstract][Full Text] [Related]
39. Radiotherapy quality assurance in clinical trials.
Perez CA; Gardner P; Glasgow GP
Int J Radiat Oncol Biol Phys; 1984 Jun; 10 Suppl 1():119-25. PubMed ID: 6735787
[TBL] [Abstract][Full Text] [Related]
40. Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: results of the Dummy Run procedure.
Fenton PA; Hurkmans C; Gulyban A; van der Leer J; Matzinger O; Poortmans P; Collette L; Bolla M
Radiother Oncol; 2013 Jun; 107(3):346-51. PubMed ID: 23707151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
